Thomas McEachin insider trades: Surgalign Holdings (SRGA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Thomas reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 16, 2021 | SRGA | ↑ Buy | 20,000 | $1.03 | $21K | Direct | Aug 17, 2021 (1d) |
| May 2, 2017 | RTIX | ↑ Buy | 4,500 | $4.35 | $20K | Direct | May 3, 2017 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Thomas McEachin's insider trades
Thomas McEachin is a director at Surgalign Holdings (SRGA). Since May 2, 2017, Thomas has reported 2 open-market purchases worth $40K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (21 filings), gifts (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SRGA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.